Search -

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Todd Neale

June 06, 2025

News Daily News

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

Todd Neale

April 12, 2024

News Daily News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Todd Neale

January 12, 2024

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Caitlin E. Cox

June 13, 2023

News Daily News

A Simple Nudge Moves the Needle on Statin Prescribing

Michael O'Riordan

December 02, 2022

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Shelley Wood

May 06, 2020

News Daily News

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Shelley Wood

February 14, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

Shelley Wood

May 01, 2019

News Daily News

Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors

Michael O'Riordan

June 13, 2018

News Daily News

FDA’s ‘Medical Device Safety Action Plan’ Focuses on Product Life Cycles and Preventing Cyberattacks

L.A. McKeown

April 20, 2018

News Daily News

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

L.A. McKeown

January 11, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Daily News

Alirocumab to Remain On Market While Companies Clash Over Patents

Michael O'Riordan

February 09, 2017

News Daily News

FDA’s Latest Move Against Aspirin for CVD Primary Prevention: A Picture Is Worth 11 Words

Shelley Wood

January 13, 2017

Advertisement

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

A Simple Nudge Moves the Needle on Statin Prescribing

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

TCTMD’s Top 10 Most Popular Stories for April 2019

Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors

FDA’s ‘Medical Device Safety Action Plan’ Focuses on Product Life Cycles and Preventing Cyberattacks

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

TCTMD’s Top 10 Most Popular Stories for April 2017

Alirocumab to Remain On Market While Companies Clash Over Patents

FDA’s Latest Move Against Aspirin for CVD Primary Prevention: A Picture Is Worth 11 Words

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content